Jennifer Schlegel

Jennifer Schlegel, PhD, is a Director of CMC and Regulatory-CMC at Magenta Therapeutics. Prior roles have included both CMC leadership and regulatory-CMC in a consulting capacity and with large pharma. She received her Bachelor of Science degree in Chemistry from Southern Oregon University and her PhD in Molecular Biology from the University of Colorado – Anschutz Medical Campus.